World's Best Scientists 2026 revealed!
Aleš Linhart

Aleš Linhart

D-Index & Metrics

Medicine

D-Index
72
Citations
68101
World Ranking
19738
National Ranking
13

Aleš Linhart publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Aleš Linhart sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 496 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Aleš Linhart D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Aleš Linhart sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 72 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Aleš Linhart is affiliated with Charles University in the Czech Republic and has a significant body of work in the field of medicine, focusing primarily on cardiology and cardiovascular medicine.

Their recent notable publications include:

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, 2021, European Heart Journal
  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice, 2021, European Heart Journal
  • 2023 ESC Guidelines for the management of acute coronary syndromes, 2023, European Heart Journal
  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, 2022, European Heart Journal
  • 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, 2022, European Heart Journal

The scientist frequently collaborates with several co-authors, including Gabriela Dostálová, Derralynn Hughes, Jan Bělohlávek, Miloš Táborský, and Štěpán Havránek, reflecting a collaborative research approach.

Aleš Linhart's work appears regularly in journals such as:

  • Cor et Vasa
  • Molecular Genetics and Metabolism
  • European Heart Journal
  • ESC Heart Failure
  • European Heart Journal - Cardiovascular Imaging

Their research spans several subfields within medicine, particularly:

  • Cardiology and Cardiovascular Medicine
  • Physiology
  • Surgery
  • Molecular Biology
  • Pulmonary and Respiratory Medicine

Main topics of their research encompass:

  • Lysosomal Storage Disorders Research
  • Carbohydrate Chemistry and Synthesis
  • Trypanosoma species research and implications
  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • Pulmonary Hypertension Research and Treatments

Best Publications

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

    Gilles Montalescot;Udo Sechtem;Stephan Achenbach;Felicita Andreotti

  • 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy : The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)

    Michele Brignole;Angelo Auricchio;Gonzalo Baron-Esquivias;Pierre Bordachar

  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Frank L J Visseren;François Mach;Yvo M Smulders;David Carballo

  • 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

    Stephan Windecker;Philippe Kolh;Fernando Alfonso;Jean-Philippe Collet

  • Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

    Alida L. P. Caforio;Sabine Pankuweit;Eloisa Arbustini;Cristina Basso

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice : a position statement of the ESC working group on myocardial and pericardial diseases

    Yigal M Pinto;Perry M Elliott;Eloisa Arbustini;Yehuda Adler

  • Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

    A. Mehta;R. Ricci;U. Widmer;F. Dehout

  • Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

    Pablo Garcia-Pavia;Claudio Rapezzi;Yehuda Adler;Michael Arad

  • Darapladib for preventing ischemic events in stable coronary heart disease.

    Harvey D. White;Claes Held;Ralph Stewart;Elizabeth Tarka

  • Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

    G Habib;P A Erba;P A Erba;B Iung;E Donal

  • Fabry disease revisited: Management and treatment recommendations for adult patients

    Alberto Ortiz;Dominique P. Germain;Robert J. Desnick;Juan Politei

  • Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

    Ales Linhart;Christoph Kampmann;José L Zamorano;Gere Sunder-Plassmann

  • Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases

    Claudio Rapezzi;Eloisa Arbustini;Alida L P Caforio;Philippe Charron

  • Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism.

    Jan Bĕlohlávek;Vladimír Dytrych;Aleš Linhart

  • Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey

    A Mehta;J T R Clarke;R Giugliani;P Elliott

  • Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

    A. Mehta;M. Beck;P. Elliott;R. Giugliani

  • New insights in cardiac structural changes in patients with Fabry's disease.

    Aleš Linhart;Tomáš Paleček;Jan Bultas;James J. Ferguson

  • Chronic thromboembolic pulmonary hypertension

    Michael Aschermann;Pavel Jansa;David Ambrož;Pavel Poláček

Frequent Co-Authors

Perry M. Elliott
Perry M. Elliott University College London
Renata Cifkova
Renata Cifkova Charles University
Derralynn Hughes
Derralynn Hughes Royal Free London NHS Foundation Trust
Petr Widimsky
Petr Widimsky Charles University
Atul Mehta
Atul Mehta The Royal Free Hospital
Milan Sonka
Milan Sonka University of Iowa
José Luis Zamorano
José Luis Zamorano Hospital Ramon y Cajal
Massimo F. Piepoli
Massimo F. Piepoli Sant'Anna School of Advanced Studies
Christoph Wanner
Christoph Wanner University of Würzburg
Patrizio Lancellotti
Patrizio Lancellotti University of Liège

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring alternatives or complementary paths to studying Medicine in the USA, there are many online degrees and career options to consider. Nursing is a popular choice, and prospective students often ask, "whats the easiest nursing program to get into?" Some schools offer streamlined admissions without demanding prerequisites or entrance exams.

For those eager to start working sooner, medical billing and coding schools with financial aid are an accessible way into the healthcare field, blending clinical knowledge with administrative skills. Similarly, students who worry about standardized testing can look into nursing schools that don't require teas or hesi for admission, making the application process more straightforward.

Those interested in leadership or administrative roles may benefit from a healthcare administration associate degree online, which prepares graduates for entry-level management in healthcare settings. Exploring these options can open doors to rewarding healthcare careers even beyond the traditional path of a medical degree.

Best Scientists Citing Aleš Linhart

Trending Scientists